サマリー

インフルエンザワクチンは、接種後2週間以内に体内に抗体ができることでインフルエンザを治療します。この抗体は、ワクチンに含まれる弱毒化されたウイルスの助けを借りて、感染を防ぎます。これらのワクチンには、インフルエンザウイルスの死滅株または不活性化株が含まれています。
市場分析と洞察。パンデミックインフルエンザワクチンの世界市場
COVID-19のパンデミックにより、パンデミックインフルエンザワクチンの世界市場規模は、2022年に100万米ドルと推定され、2028年には再調整後の市場規模が100万米ドルになると予測されています（検討期間中のCAGRは％）。この健康危機による経済的変化を十分に考慮し、2021年にパンデミックインフルエンザワクチンの世界市場の％を占めていたホールウイルスワクチンは、COVID-19後の期間に改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されています。一方、「子供用（6ヶ月～3年）」セグメントは、この予測期間中、年率％で変化しています。
中国のパンデミックインフルエンザワクチンの市場規模は2021年に百万米ドル、米国と欧州のパンデミックインフルエンザワクチンはそれぞれ百万米ドルと百万米ドルとなっています。2021年の米国の割合は%で、中国と欧州はそれぞれ%と%で、中国の割合は2028年に%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのパンデミックインフルエンザワクチン市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%となっています。
パンデミックインフルエンザワクチンの世界的な主要メーカーには、CSL、GSK、Sanofi Pasteur、Mylan、AstraZeneca、Pfizer、Johnson & Johnsonなどがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
世界のパンデミック・インフルエンザ・ワクチンのスコープとセグメント
パンデミックインフルエンザワクチン市場は、タイプ別、アプリケーション別に分類されています。世界のパンデミック・インフルエンザ・ワクチン市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
ホール・ウイルス・ワクチン
スプリットウイルスワクチン
サブユニットワクチン
アプリケーション別セグメント
小児用（6ヶ月～3歳）
成人および3歳以上の小児用
会社別
CSL
GSK
サノフィパスツール
マイラン
アストラゼネカ
ファイザー
ジョンソン・エンド・ジョンソン
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.

ページTOPに戻る

目次

1 Study Coverage
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.3 Market by Application
1.3.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pandemic Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pandemic Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pandemic Influenza Vaccine Sales by Region
2.4.1 Global Pandemic Influenza Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pandemic Influenza Vaccine by Region (2023-2028)
2.5 Global Pandemic Influenza Vaccine Revenue by Region
2.5.1 Global Pandemic Influenza Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pandemic Influenza Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Pandemic Influenza Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pandemic Influenza Vaccine in 2021
3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Pandemic Influenza Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2021
3.3 Global Pandemic Influenza Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pandemic Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pandemic Influenza Vaccine Sales by Type
4.1.1 Global Pandemic Influenza Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pandemic Influenza Vaccine Revenue by Type
4.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pandemic Influenza Vaccine Price by Type
4.3.1 Global Pandemic Influenza Vaccine Price by Type (2017-2022)
4.3.2 Global Pandemic Influenza Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pandemic Influenza Vaccine Sales by Application
5.1.1 Global Pandemic Influenza Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pandemic Influenza Vaccine Revenue by Application
5.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pandemic Influenza Vaccine Price by Application
5.3.1 Global Pandemic Influenza Vaccine Price by Application (2017-2022)
5.3.2 Global Pandemic Influenza Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pandemic Influenza Vaccine Market Size by Type
6.1.1 North America Pandemic Influenza Vaccine Sales by Type (2017-2028)
6.1.2 North America Pandemic Influenza Vaccine Revenue by Type (2017-2028)
6.2 North America Pandemic Influenza Vaccine Market Size by Application
6.2.1 North America Pandemic Influenza Vaccine Sales by Application (2017-2028)
6.2.2 North America Pandemic Influenza Vaccine Revenue by Application (2017-2028)
6.3 North America Pandemic Influenza Vaccine Market Size by Country
6.3.1 North America Pandemic Influenza Vaccine Sales by Country (2017-2028)
6.3.2 North America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pandemic Influenza Vaccine Market Size by Type
7.1.1 Europe Pandemic Influenza Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Type (2017-2028)
7.2 Europe Pandemic Influenza Vaccine Market Size by Application
7.2.1 Europe Pandemic Influenza Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pandemic Influenza Vaccine Revenue by Application (2017-2028)
7.3 Europe Pandemic Influenza Vaccine Market Size by Country
7.3.1 Europe Pandemic Influenza Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pandemic Influenza Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pandemic Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pandemic Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Pandemic Influenza Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pandemic Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pandemic Influenza Vaccine Market Size by Type
9.1.1 Latin America Pandemic Influenza Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pandemic Influenza Vaccine Market Size by Application
9.2.1 Latin America Pandemic Influenza Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pandemic Influenza Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pandemic Influenza Vaccine Market Size by Country
9.3.1 Latin America Pandemic Influenza Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pandemic Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pandemic Influenza Vaccine Market Size by Application
10.2.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pandemic Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pandemic Influenza Vaccine Industry Chain Analysis
12.2 Pandemic Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pandemic Influenza Vaccine Production Mode & Process
12.4 Pandemic Influenza Vaccine Sales and Marketing
12.4.1 Pandemic Influenza Vaccine Sales Channels
12.4.2 Pandemic Influenza Vaccine Distributors
12.5 Pandemic Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pandemic Influenza Vaccine Industry Trends
13.2 Pandemic Influenza Vaccine Market Drivers
13.3 Pandemic Influenza Vaccine Market Challenges
13.4 Pandemic Influenza Vaccine Market Restraints
14 Key Findings in The Global Pandemic Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer